143 results on '"McAleer, Mary F"'
Search Results
2. Safety and Efficacy of Dose-Escalated Radiation Therapy With a Simultaneous Integrated Boost for the Treatment of Spinal Metastases
3. Outcomes and Pattern of Care for Spinal Myxopapillary Ependymoma in the Modern Era—A Population-Based Observational Study
4. Hypofractionated radiotherapy for glioblastoma: A large institutional retrospective assessment of 2 approaches
5. A phase II clinical trial of frameless fractionated stereotactic radiotherapy for brain metastases
6. Desmoplastic Small Round Cell Tumor Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Results of a Phase 2 Trial
7. Outcomes for pediatric patients with central nervous system germ cell tumors treated with proton therapy
8. Proton versus conventional radiotherapy for pediatric salivary gland tumors: Acute toxicity and dosimetric characteristics
9. Neurosurgical management of brain metastases
10. A phase II clinical trial of frameless, fractionated stereotactic radiation therapy for brain metastases.
11. Submillimeter alignment of more than three contiguous vertebrae in spinal SRS/SBRT with 6‐degree couch
12. White paper: Onco-fertility in pediatric patients with Wilms tumor
13. White paper: Oncofertility in pediatric patients with Wilms tumor
14. Pilocytic astrocytoma with leptomeningeal dissemination
15. Phase II Trial of Proton Therapy vs. Photon IMRT for GBM: Secondary Analysis Comparison of Progression Free Survival between RANO vs. Clinical Assessment
16. Observed‐to‐expected incidence ratios of second malignant neoplasms after radiation therapy for medulloblastoma: A Surveillance, Epidemiology, and End Results analysis
17. Development of second primary tumors and outcomes in medulloblastoma by treatment modality: A Surveillance, Epidemiology, and End Results analysis
18. Influence of Induction Chemotherapy and Class of Cytotoxics on Pathologic Response and Survival After Preoperative Chemoradiation in Patients With Carcinoma of the Esophagus
19. Time-Driven, Activity-Based Cost Analysis of Radiation Treatment Options for Spinal Metastases
20. Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma
21. Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy
22. Timing of Radiation Therapy for Parameningeal Rhabdomyosarcoma With Intracranial Extension
23. Patterns of Failure With Proton Therapy for Head and Neck Rhabdomyosarcoma
24. Recurrent desmoplastic small round cell tumor responding to an mTOR inhibitor containing regimen
25. Submillimeter alignment of more than three contiguous vertebrae in spinal SRS / SBRT with 6‐degree couch
26. 7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial
27. Spot scanning proton therapy for craniopharyngioma
28. Gamma knife stereotactic radiosurgery in the treatment of brainstem metastases: The MD Anderson experience
29. Outcomes and Acute Toxicities of Proton Therapy for Pediatric Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System
30. Proton Beam Therapy Versus Conformal Photon Radiation Therapy for Childhood Craniopharyngioma: Multi-institutional Analysis of Outcomes, Cyst Dynamics, and Toxicity
31. Prospective evaluation of target and spinal cord motion and dosimetric changes with respiration in spinal stereotactic body radiation therapy utilizing 4-D CT.
32. Predictors of Survival in Contemporary Practice After Initial Radiosurgery for Brain Metastases
33. Pilocytic astrocytoma with leptomeningeal dissemination
34. Whole Abdominopelvic Intensity-Modulated Radiation Therapy for Desmoplastic Small Round Cell Tumor After Surgery
35. Vertebral compression fracture risk after stereotactic body radiotherapy for spinal metastases
36. Toxicity and Patterns of Failure of Adaptive/Ablative Proton Therapy for Early-Stage, Medically Inoperable Non–Small Cell Lung Cancer
37. Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy
38. Daily Alignment Results of In-Room Computed Tomography–Guided Stereotactic Body Radiation Therapy for Lung Cancer
39. Interfractional Reproducibility of Lung Tumor Location Using Various Methods of Respiratory Motion Mitigation
40. Predictive Value of 18F-Fluorodeoxyglucose Uptake by Positron Emission Tomography for Non-Small Cell Lung Cancer Patients Treated with Radical Radiotherapy
41. Patterns of Care and Locoregional Treatment Outcomes in Older Esophageal Cancer Patients: The SEER-Medicare Cohort
42. Potential Dosimetric Benefits of Four-Dimensional Radiation Treatment Planning
43. Stereotactic Body Radiation Therapy in Centrally and Superiorly Located Stage I or Isolated Recurrent Non–Small-Cell Lung Cancer
44. Determination of Respiratory Motion for Distal Esophagus Cancer Using Four-Dimensional Computed Tomography
45. Dose-Dependent Pulmonary Toxicity After Postoperative Intensity-Modulated Radiotherapy for Malignant Pleural Mesothelioma
46. PD5-2-6: Hypofractionated stereotactic body radiotherapy in patients with peripherally or centrally located medically inoperable stage I or isolated recurrent non-small cell lung cancer
47. PD4-1-6: Acute esophageal reactions from proton beam therapy and concurrent chemotherapy for non-small cell lung cancer (NSCLS): Reduction in incidence and severity despite higher doses
48. Recurrent desmoplastic small round cell tumor responding to an mTOR inhibitor containing regimen.
49. Hypofractionated stereotactic body radiotherapy in patients with peripherally or centrally located medically inoperable stage I or isolated recurrent non-small cell lung cancer.
50. Acute esophageal reactions from proton beam therapy and concurrent chemotherapy for non-small cell lung cancer (NSCLS): Reduction in incidence and severity despite higher doses.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.